Home Page

EMERYVILLE, Calif., April 23, 2019 /PRNewswire/ -- Alice Reier, MD is recognized by the Continental Who's Who as a Pinnacle Lifetime Achiever in the field of Medicine as an Oncologist at her Private Practice.

DUBLIN, April 23, 2019 /PRNewswire/ -- The Read more ››

NEW YORK, April 23, 2019 /PRNewswire/ -- The nation's largest suicide prevention organization, the American Foundation... Read more ››

BIRMINGHAM, Ala., April 23, 2019 /PRNewswire/ -- Bridge Therapeutics, an innovative startup pharmaceutical... Read more ››

DALLAS, April 23, 2019 /PRNewswire/ -- Dallas plastic surgeon and Rhinoplasty Surgeon, Dr. Rod J. Rohrich, an internationally known Read more ››

ATLANTA, April 23, 2019 /PRNewswire/ -- Eye Consultants of Atlanta has expanded their Cumberland, GA practice to include... Read more ››

MISSISSAUGA, ON, April 23, 2019 /CNW/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products today announced that Jesse Ledger, the Company's President & Chief Executive... Read more ››

Company to showcase its innovative Alzheimer's, Parkinson's and ALS programs

Also provides an update on proposed acquisition of Solace Management Group Inc. and expected branding and distribution initiatives to follow.

- Opens the Door for Canadian and International Sales and White Labeling -

OSLO, Norway, April 23, 2019 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO) a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for multiple cancer indications, announces that the Company and its collaborators will present new interim clinical and biomarker... Read more ››

BANGALORE, April 23, 2019 /PRNewswire/ --

SHANGHAI, April 23, 2019 /PRNewswire/ -- China has recently emphasized that openness and cooperation are a major driving force behind dynamic international economic and trade activities, and that China will stimulate the potential for increased imports, continue to broaden market access, foster... Read more ››

TAIPEI, Taiwan, April 23, 2019 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") announced today that Phase III trial of the combination therapy Furaprevir - Yimitasvir for the treatment of chronic hepatitis C patients has been initiated. The combination regimen of Furaprevir and... Read more ››